Inhibrx Biosciences, Inc. (INBX)

79.49 +4.39 (+5.85%) USD  |  NASDAQ  |  Jan 22, 16:00
79.52 +0.03 (+0.04%) After-Hours: 20:00
More

Inhibrx Biosciences Total Expenses (Quarterly)

Total Expenses (Quarterly) Chart

View Total Expenses (Quarterly) for INBX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (Quarterly) Range, Past 5 Years

View Total Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (Quarterly) Benchmarks

View Total Expenses (Quarterly) Benchmarks
Start Trial
Agenus, Inc. Upgrade
Ligand Pharmaceuticals, Inc. Upgrade
Armata Pharmaceuticals, Inc. Upgrade
Adverum Biotechnologies, Inc. Upgrade
Pelthos Therapeutics, Inc. Upgrade

Total Expenses (Quarterly) Related Metrics

Net Income (Quarterly) Upgrade
EPS Diluted (Quarterly) Upgrade
Enterprise Value Upgrade
Earnings Yield Upgrade
Normalized Earnings Yield Upgrade